J A Kanis1, H Johansson, A Oden, C Cooper, E V McCloskey. 1. WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK, w.j.pontefract@sheffield.ac.uk.
Abstract
UNLABELLED: The worldwide uptake of FRAX is described. INTRODUCTION: The aim of this report was to determine the usage of FRAX worldwide over a 1-year period from 1 May 2012. METHODS: The number of FRAX calculations from each country was assessed over a 1-year period and expressed as calculations per million of the population aged 50 years or more. Countries were colour coded according to usage to populate a world map. RESULTS: Over the index year, there were estimated to be 2,391,639 calculations sourced from 173 counties. Uptake was high in North America, the Antipodes and most countries of Europe; intermediate in Latin America and the Middle East; and very low in Africa and much of South East Asia. CONCLUSIONS: It is expected that the comparative data will encourage the development of new FRAX models and the uptake of FRAX into assessment guidelines.
UNLABELLED: The worldwide uptake of FRAX is described. INTRODUCTION: The aim of this report was to determine the usage of FRAX worldwide over a 1-year period from 1 May 2012. METHODS: The number of FRAX calculations from each country was assessed over a 1-year period and expressed as calculations per million of the population aged 50 years or more. Countries were colour coded according to usage to populate a world map. RESULTS: Over the index year, there were estimated to be 2,391,639 calculations sourced from 173 counties. Uptake was high in North America, the Antipodes and most countries of Europe; intermediate in Latin America and the Middle East; and very low in Africa and much of South East Asia. CONCLUSIONS: It is expected that the comparative data will encourage the development of new FRAX models and the uptake of FRAX into assessment guidelines.
Authors: D S Domiciano; L G Machado; C P Figueiredo; V F Caparbo; R M Oliveira; P R Menezes; R M R Pereira Journal: Osteoporos Int Date: 2020-10-10 Impact factor: 4.507
Authors: John A Kanis; Nicholas C Harvey; Cyrus Cooper; Helena Johansson; Anders Odén; Eugene V McCloskey Journal: Arch Osteoporos Date: 2016-07-27 Impact factor: 2.617
Authors: Nicholas R Fuggle; Elizabeth M Curtis; Kate A Ward; Nicholas C Harvey; Elaine M Dennison; Cyrus Cooper Journal: Nat Rev Endocrinol Date: 2019-09 Impact factor: 43.330